0115-0691 : Zolmitriptan 2.5 mg Disintegrating Tablet


NDC0115-0691
Labeler: Global Pharmaceuticals, Division of Impax Laboratories Inc.
Product Type: Human Prescription Drug
Drug Name:  Zolmitriptan Orally Disintegrating
Dosage Form: Oral Tablet, Orally Disintegrating
Application #: NDA021231
Rev. Date: 


Appearance:


Markings: Z
Shapes:  Round
Colors:  White
Size (mm): 6
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Z: (0115-0691) Zolmitriptan 2.5 mg Disintegrating Tablet by Global Pharmaceuticals, Division of Impax Laboratories Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0115-0691-51: 1 BLISTER PACK IN 1 CARTON (0115‑0691‑51) > 6 TABLET, ORALLY DISINTEGRATING IN 1 BLISTER PACK

Active Ingredients:

  • Zolmitriptan

Dosage Strength:

  • 2.5 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Magnesium Stearate
  • Crospovidone
  • Aspartame
  • Sodium Bicarbonate
  • Anhydrous Citric Acid
  • Silicon Dioxide
  • Orange
  • Mannitol

Pharmaceutical Classes:

  • Serotonin 1b Receptor Agonists [MoA]
  • Serotonin 1d Receptor Agonists [MoA]
  • Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Related Products:

Based on records with the same trade name.
  • 0115-0692 Zolmitriptan 5 mg Disintegrating Tablet by Global Pharmaceuticals, Division of Impax Laboratories Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0115-0691 QR Code

< Prev: 0115-0672Next: 0115-0692 >

Related Discussions:

zolmitriptan
label of ascotop and zomig...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.